close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BioCorRx Inc

Recent news which mentions BioCorRx Inc

BioCorRx Reports Business Update for the First Quarter of 2025
Tickers BICX
Tags en/US BioCorRx Inc OTCM:BICX
From TheNewswire.com - RSS (Media)
BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC
Tickers BICX R
Tags OTCM:BICX en/US BioCorRx Inc
From TheNewswire.com - RSS (Media)
BioCorRx Reports Business Update for the First Quarter of 2024
Tickers BICX
Tags BioCorRx Inc OTCM:BICX
From TheNewswire.com - RSS (Media)
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
Tickers BICX
Tags BioCorRx Inc OTCM:BICX
From TheNewswire.com - RSS (Media)
BioCorRx Reports Business Update for 2023
Tickers BICX
Tags OTCM:BICX BioCorRx Inc
From TheNewswire.com - RSS (Media)
BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
Tickers BICX
Tags BioCorRx Inc OTCM:BICX
From TheNewswire.com - RSS (Media)
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
Tickers BICX
Tags OTCM:BICX BioCorRx Inc
From TheNewswire.com - RSS (Media)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today